Spain
· Delayed Price · Currency is EUR Árima Real Estate SOCIMI Statistics
Total Valuation
BME:ARM has a market cap or net worth of EUR 200.38 million. The enterprise value is 295.82 million.
| Market Cap | 200.38M |
| Enterprise Value | 295.82M |
Important Dates
The next estimated earnings date is Monday, May 19, 2025.
| Earnings Date | May 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:ARM has 25.96 million shares outstanding. The number of shares has decreased by -1.05% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 25.96M |
| Shares Change (YoY) | -1.05% |
| Shares Change (QoQ) | +0.65% |
| Owned by Insiders (%) | 20.17% |
| Owned by Institutions (%) | 150.13% |
| Float | 14.95M |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.45 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.97 |
| EV / Sales | 24.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.53, with a Debt / Equity ratio of 0.50.
| Current Ratio | 0.53 |
| Quick Ratio | 0.44 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.90 |
Financial Efficiency
Return on equity (ROE) is -12.46% and return on invested capital (ROIC) is -3.53%.
| Return on Equity (ROE) | -12.46% |
| Return on Assets (ROA) | -3.41% |
| Return on Invested Capital (ROIC) | -3.53% |
| Return on Capital Employed (ROCE) | -6.09% |
| Revenue Per Employee | 1.35M |
| Profits Per Employee | -3.00M |
| Employee Count | 9 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.52% in the last 52 weeks. The beta is 0.46, so BME:ARM's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +23.52% |
| 50-Day Moving Average | 7.89 |
| 200-Day Moving Average | 8.29 |
| Relative Strength Index (RSI) | 55.07 |
| Average Volume (20 Days) | 40 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:ARM had revenue of EUR 12.18 million and -26.97 million in losses. Loss per share was -1.04.
| Revenue | 12.18M |
| Gross Profit | 12.18M |
| Operating Income | -18.23M |
| Pretax Income | -26.97M |
| Net Income | -26.97M |
| EBITDA | -13.91M |
| EBIT | -18.23M |
| Loss Per Share | -1.04 |
Balance Sheet
The company has 5.04 million in cash and 100.48 million in debt, giving a net cash position of -95.44 million or -3.68 per share.
| Cash & Cash Equivalents | 5.04M |
| Total Debt | 100.48M |
| Net Cash | -95.44M |
| Net Cash Per Share | -3.68 |
| Equity (Book Value) | 202.63M |
| Book Value Per Share | 7.81 |
| Working Capital | -7.72M |
Cash Flow
| Operating Cash Flow | -13.46M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -149.65% and -221.38%.
| Gross Margin | 100.00% |
| Operating Margin | -149.65% |
| Pretax Margin | -221.38% |
| Profit Margin | -221.38% |
| EBITDA Margin | -114.15% |
| EBIT Margin | -149.65% |
| FCF Margin | n/a |
Dividends & Yields
BME:ARM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.05% |
| Shareholder Yield | 1.05% |
| Earnings Yield | -13.46% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |